Clinical trial
Multi-arm Optimization of Stroke Thrombolysis (MOST): a Single Blinded, Randomized Controlled Adaptive, Multi-arm, Adjunctive-thrombolysis Efficacy Trial in Ischemic Stroke
NCT03735979 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-arm Optimization of Stroke Thrombolysis (MOST): a Single Blinded, Randomized Controlled Adaptive, Multi-arm, Adjunctive-thrombolysis Efficacy Trial in Ischemic Stroke
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 15, 2019
- Completion date
- October 31, 2024
- Enrollment
- 514 (actual)
- Sites
- 61
Conditions
As the registry lists them; a condition with its own page is linked.
acute ischemic stroke